Neurology, Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK
Ophthalmology, Musgrove Park Hospital, Taunton, UK.
Pract Neurol. 2024 Sep 13;24(5):410-412. doi: 10.1136/pn-2023-003998.
A man in his 90s presented with acute monocular loss of vision; the emergency department triage alerted the stroke team. He underwent urgent parallel assessments by the stroke and ophthalmology teams and was diagnosed with central retinal artery occlusion. The ultimate decision was made to manage him conservatively, rather than with intravenous thrombolysis, and his visual function has remained poor. We discuss the current evidence for using intravenous thrombolysis in people with central retinal artery occlusion and use this case to exemplify the practical issues that must be overcome if ongoing randomised clinical trials of central retinal artery occlusion confirm a definite benefit from using intravenous thrombolysis.
一位 90 多岁的男性出现急性单眼视力丧失;急诊分诊提醒卒中团队。他接受了卒中团队和眼科团队的紧急平行评估,被诊断为视网膜中央动脉阻塞。最终决定对他进行保守治疗,而不是静脉溶栓治疗,他的视力功能仍然很差。我们讨论了目前在视网膜中央动脉阻塞患者中使用静脉溶栓的证据,并使用该病例来说明如果正在进行的视网膜中央动脉阻塞随机临床试验证实静脉溶栓有明确获益,那么必须克服的实际问题。